Franklin M Berger

Director · 2 filings · Latest: Jun 18, 2026

Atea Pharmaceuticals, Inc.

Kezar Life Sciences, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
AVIR	Franklin M Berger	Director	Jun 18, 2026	Option Exercise	$0.00	29,600	—	536,097	Jun 23 9:00 PM
AVIR	Franklin Berger	—	Dec 10, 2024	Proposed Sale	$2.85	359,606	$1.0M	—	Dec 10 10:17 PM